Sehgal Arvind, Guaran Robert
Department of Neonatal Intensive Care, Liverpool Hospital, South Western Sydney Area Health Service, Sydney, New South Wales, Australia.
Indian J Chest Dis Allied Sci. 2005 Jul-Sep;47(3):187-92.
Respiratory diseases are the commonest cause of morbidity and mortality in newborn babies. During the past few years several new modalities of treatment like surfactant have been introduced. One of them, and probably the most fascinating, is of liquid ventilation. Partial liquid ventilation, on which much of the existing research has concentrated, requires partial filling of lungs with perfluorocarbons (PFC's) and ventilation with gas tidal volumes using a conventional mechanical ventilators. Various physico-chemical properties of PFC's make them the ideal media. It results in a dramatic improvement in lung compliance and oxygenation and decline in mean airway pressure and oxygen requirements. It shows further promise for lung lavaging procedures, pulmonary image enhancement, pulmonary administration of drugs and as a technique to increase functional residual capacity in lung hypoplasia syndromes. There are no long-term side effect reported.
呼吸系统疾病是新生儿发病和死亡的最常见原因。在过去几年中,已经引入了几种新的治疗方法,如表面活性剂。其中之一,可能也是最引人入胜的,是液体通气。现有的大部分研究都集中在部分液体通气上,这需要用全氟化碳(PFC)部分填充肺部,并使用传统机械通气机进行气体潮气量通气。PFC的各种物理化学性质使其成为理想的介质。它能显著改善肺顺应性和氧合,降低平均气道压和氧需求。它在肺灌洗程序、肺部图像增强、肺部药物给药以及作为增加肺发育不全综合征功能残气量的技术方面显示出进一步的前景。目前尚无长期副作用的报道。